| Year |
Citation |
Score |
| 2023 |
Garmendia I, Varthaman A, Marmier S, Angrini M, Matchoua I, Darbois-Delahousse A, Josseaume N, Foy PE, Roumenina LT, Naouar N, Meylan M, Sibéril S, Russick J, Joubert PE, Leroy K, ... ... Cremer I, et al. Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment. Cancer Immunology Research. OF1-OF16. PMID 36883368 DOI: 10.1158/2326-6066.CIR-22-0534 |
0.5 |
|
| 2022 |
Leonardi L, Siberil S, Alifano M, Cremer I, Joubert PE. Autophagy-Related Gene Signature Highlights Metabolic and Immunogenic Status of Malignant Cells in Non-Small Cell Lung Cancer Adenocarcinoma. Cancers. 14. PMID 35884522 DOI: 10.3390/cancers14143462 |
0.497 |
|
| 2022 |
Velut Y, Decroix E, Blons H, Alifano M, Leroy K, Petitprez F, Boni A, Garinet S, Biton J, Cremer I, Wislez M, Boudou-Rouquette P, Arrondeau J, Goldwasser F, Fournel L, et al. SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils. Lung Cancer (Amsterdam, Netherlands). 169: 13-21. PMID 35597058 DOI: 10.1016/j.lungcan.2022.05.001 |
0.433 |
|
| 2022 |
Leonardi L, Sibéril S, Alifano M, Cremer I, Joubert PE. [Autophagy modulation by viruses: An important role in tumor progression]. Medecine Sciences : M/S. 38: 159-167. PMID 35179470 DOI: 10.1051/medsci/2022010 |
0.431 |
|
| 2021 |
Leonardi L, Sibéril S, Alifano M, Cremer I, Joubert PE. Autophagy Modulation by Viral Infections Influences Tumor Development. Frontiers in Oncology. 11: 743780. PMID 34745965 DOI: 10.3389/fonc.2021.743780 |
0.355 |
|
| 2021 |
Joseph A, Juncheng P, Mondini M, Labaied N, Loi M, Adam J, Lafarge A, Astesana V, Obrist F, Klein C, Bloy N, Stoll G, Signolle N, Genestie C, Damotte D, ... ... Cremer I, et al. Metabolic features of cancer cells impact immunosurveillance. Journal For Immunotherapy of Cancer. 9. PMID 34162714 DOI: 10.1136/jitc-2021-002362 |
0.362 |
|
| 2021 |
Daugan MV, Revel M, Russick J, Dragon-Durey MA, Gaboriaud C, Robe-Rybkine T, Poillerat V, Grunenwald A, Lacroix G, Bougouin A, Meylan M, Verkarre V, Oudard SM, Mejean A, Vano YA, ... ... Cremer I, et al. Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s. Cancer Immunology Research. PMID 34039653 DOI: 10.1158/2326-6066.CIR-20-0532 |
0.425 |
|
| 2021 |
Daugan MV, Revel M, Thouenon R, Dragon-Durey MA, Robe-Rybkine T, Torset C, Merle NS, Noe R, Verkarre V, Oudard SM, Mejean A, Validire P, Cathelineau X, Sanchez-Salas R, Pickering MC, ... Cremer I, et al. Intracellular Factor H drives tumor progression independently of the complement cascade. Cancer Immunology Research. PMID 34039652 DOI: 10.1158/2326-6066.CIR-20-0787 |
0.549 |
|
| 2020 |
Dubuisson A, Fahrner JE, Goubet AG, Terrisse S, Voisin N, Bayard C, Lofek S, Drubay D, Bredel D, Mouraud S, Susini S, Cogdill A, Rebuffet L, Ballot E, Jacquelot N, ... ... Cremer I, et al. Immunodynamics of explanted human tumors for immuno-oncology. Embo Molecular Medicine. e12850. PMID 33372722 DOI: 10.15252/emmm.202012850 |
0.31 |
|
| 2020 |
Russick J, Joubert PE, Gillard-Bocquet M, Torset C, Meylan M, Petitprez F, Dragon-Durey MA, Marmier S, Varthaman A, Josseaume N, Germain C, Goc J, Dieu-Nosjean MC, Validire P, Fournel L, ... ... Cremer I, et al. Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions. Journal For Immunotherapy of Cancer. 8. PMID 33067317 DOI: 10.1136/jitc-2020-001054 |
0.54 |
|
| 2020 |
Russick J, Torset C, Hemery E, Cremer I. NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends. Seminars in Immunology. 101407. PMID 32900565 DOI: 10.1016/j.smim.2020.101407 |
0.501 |
|
| 2020 |
Boulle G, Velut Y, Mansuet-Lupo A, Gibault L, Blons H, Fournel L, Boni A, Cremer I, Wislez M, Duchatelle V, Trédaniel J, Hammond SA, Herbst R, Alifano M, Giraud P, et al. Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma. European Journal of Cancer (Oxford, England : 1990). 135: 221-229. PMID 32610210 DOI: 10.1016/J.Ejca.2020.04.040 |
0.477 |
|
| 2020 |
Angrini M, Varthaman A, Cremer I. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones. Advances in Experimental Medicine and Biology. 1263: 145-173. PMID 32588327 DOI: 10.1007/978-3-030-44518-8_9 |
0.541 |
|
| 2020 |
Kasikova L, Truxova I, Cremer I, Sautes-Fridman C, Kepp O, Kroemer G, Spisek R, Fucikova J. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death. Methods in Enzymology. 632: 15-25. PMID 32000894 DOI: 10.1016/Bs.Mie.2019.05.025 |
0.412 |
|
| 2020 |
Holicek P, Truxova I, Kasikova L, Vosahlikova S, Salek C, Rakova J, Holubova M, Lysak D, Cremer I, Spisek R, Fucikova J. Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood. Methods in Enzymology. 631: 277-287. PMID 31948552 DOI: 10.1016/bs.mie.2019.05.034 |
0.425 |
|
| 2020 |
Velut Y, Boulle G, Lupo AM, Gibault L, Blons H, Tredaniel J, Fournel L, Boni A, Cremer I, Wislez M, Duchatelle V, Hammond S, Alifano M, Giraud P, Damotte D. Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma Clinical Trials. 80: 4304-4304. DOI: 10.1158/1538-7445.Am2020-4304 |
0.536 |
|
| 2019 |
Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, Praznovec I, Vosahlikova S, Halaska MJ, Brtnicky T, Rob L, Presl J, Kostun J, Cremer I, Ryska A, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 7: 312. PMID 31747968 DOI: 10.1186/S40425-019-0781-Z |
0.346 |
|
| 2019 |
Hervier B, Russick J, Cremer I, Vieillard V. NK Cells in the Human Lungs. Frontiers in Immunology. 10: 1263. PMID 31275301 DOI: 10.3389/Fimmu.2019.01263 |
0.502 |
|
| 2019 |
Mansuet-Lupo A, Barritault M, Alifano M, Janet-Vendroux A, Zarmaev M, Biton J, Velut Y, Le Hay C, Cremer I, Régnard JF, Fournel L, Rance B, Wislez M, Laurent-Puig P, Herbst R, et al. Proposal for a combined histo-molecular algorithm to distinguish multiple primary adenocarcinomas from intrapulmonary metastasis in patients with multiple lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30721797 DOI: 10.1016/J.Jtho.2019.01.017 |
0.403 |
|
| 2019 |
Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 8: e1505174. PMID 30546943 DOI: 10.1080/2162402X.2018.1505174 |
0.585 |
|
| 2019 |
Lupo A, Biton J, Alifano M, Damotte D, Arrondeau J, Boudou P, Goldwasser F, Leroy K, Wislez M, Laurent-Puig P, Cremer I, Blons H, Herbst R. Abstract 573: Mutations found by targeted next generation sequencing is associated with intra-tumor immune profile and may predict response to anti-PD1 therapy in lung adenocarcinoma Immunology. DOI: 10.1158/1538-7445.Sabcs18-573 |
0.413 |
|
| 2018 |
Gayed C, Uzunhan Y, Cremer I, Vieillard V, Hervier B. Immunopathogenesis of the Anti-Synthetase Syndrome. Critical Reviews in Immunology. 38: 263-278. PMID 30806243 DOI: 10.1615/Critrevimmunol.2018025744 |
0.38 |
|
| 2018 |
Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, et al. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. Oncoimmunology. 7: e1386826. PMID 30524877 DOI: 10.1080/2162402X.2017.1386826 |
0.594 |
|
| 2018 |
Lupo A, Alifano M, Wislez M, Boulle G, Velut Y, Biton J, Cremer I, Goldwasser F, Leroy K, Damotte D. [Biomarkers predictive of PD1/PD-L1 immunotherapy in non-small cell lung cancer]. Revue De Pneumologie Clinique. 74: 339-350. PMID 30337201 DOI: 10.1016/J.Pneumo.2018.09.010 |
0.339 |
|
| 2018 |
Biton J, Mansuet-Lupo A, Pécuchet N, Alifano M, Ouakrim H, Arrondeau J, Boudou-Rouquette P, Goldwasser F, Leroy K, Goc J, Wislez M, Germain C, Laurent-Puig P, Dieu-Nosjean MC, Cremer I, et al. , and Mutations Predict Tumor Immune Profile and the Response to anti-PD-1 in Lung Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29764856 DOI: 10.1158/1078-0432.Ccr-18-0163 |
0.534 |
|
| 2018 |
Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, Damotte D, Alifano M, Validire P, Anjuère F, Cremer I, Girard N, Gossot D, Seguin-Givelet A, Dieu-Nosjean MC, et al. Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. Oncoimmunology. 7: e1423184. PMID 29721382 DOI: 10.1080/2162402X.2017.1423184 |
0.482 |
|
| 2018 |
Biton J, Ouakrim H, Dechartres A, Alifano M, Mansuet-Lupo A, Si H, Halpin R, Creasy T, Bantsimba-Malanda C, Arrondeau J, Goldwasser F, Boudou-Rouquette P, Fournel L, Roche N, Burgel PR, ... ... Cremer I, et al. Impaired Tumor-infiltrating T Cells in Patients with COPD Impacts Lung Cancer Response to PD-1 Blockade. American Journal of Respiratory and Critical Care Medicine. PMID 29518341 DOI: 10.1164/Rccm.201706-1110Oc |
0.522 |
|
| 2018 |
Dajon M, Iribarren K, Alifano M, Damotte D, Cremer I. Abstract 5752: Protumoral and pro-metastatic effects of TLR7 in lung cancer Immunology. DOI: 10.1158/1538-7445.Am2018-5752 |
0.471 |
|
| 2017 |
Hervier B, Cremer I, Vieillard V. Polyfunctionality of bona fide resident lung CD69(+) natural killer cells. The Journal of Allergy and Clinical Immunology. PMID 28528926 DOI: 10.1016/J.Jaci.2017.02.042 |
0.414 |
|
| 2017 |
Fend L, Rusakiewicz S, Adam J, Bastien B, Caignard A, Messaoudene M, Iribarren C, Cremer I, Marabelle A, Borg C, Semeraro M, Barraud L, Limacher JM, Eggermont A, Kroemer G, et al. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. Oncoimmunology. 6: e1163456. PMID 28197362 DOI: 10.1080/2162402X.2016.1163456 |
0.552 |
|
| 2017 |
Dajon M, Iribarren K, Cremer I. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword. Immunobiology. 222: 89-100. PMID 27349597 DOI: 10.1016/J.Imbio.2016.06.009 |
0.596 |
|
| 2016 |
Remark R, Lupo A, Alifano M, Biton J, Ouakrim H, Stefani A, Cremer I, Goc J, Régnard JF, Dieu-Nosjean MC, Damotte D. Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients. Oncoimmunology. 5: e1255394. PMID 28123901 DOI: 10.1080/2162402X.2016.1255394 |
0.551 |
|
| 2016 |
Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/Blood-2016-08-731737 |
0.42 |
|
| 2016 |
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790 |
0.389 |
|
| 2016 |
Stoll G, Iribarren K, Michels J, Leary A, Zitvogel L, Cremer I, Kroemer G. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. Oncoimmunology. 5: e1177692. PMID 27622029 DOI: 10.1080/2162402X.2016.1177692 |
0.456 |
|
| 2016 |
Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, Ouakrim H, Dorgham K, Méritet JF, Longchampt E, Stenzel W, Cremer I, Benveniste O, Vieillard V. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. Journal of Immunology (Baltimore, Md. : 1950). PMID 27511738 DOI: 10.4049/Jimmunol.1501902 |
0.49 |
|
| 2016 |
Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674 |
0.546 |
|
| 2016 |
Mansuet-Lupo A, Alifano M, Pécuchet N, Biton J, Becht E, Goc J, Germain C, Ouakrim H, Régnard JF, Cremer I, Laurent-Puig P, Dieu-Nosjean MC, Blons H, Damotte D. Intra-tumoral Immune Cell Densities are Associated with Lung Adenocarcinoma Gene Alterations. American Journal of Respiratory and Critical Care Medicine. PMID 27299180 DOI: 10.1164/Rccm.201510-2031Oc |
0.608 |
|
| 2016 |
Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631 |
0.486 |
|
| 2016 |
Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942 |
0.446 |
|
| 2016 |
Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C, Lupo A, Fridman WH, Dieu-Nosjean MC, Kroemer G, Sautès-Fridman C, ... Cremer I, et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Research. 76: 1746-56. PMID 26842877 DOI: 10.1158/0008-5472.Can-15-1142 |
0.656 |
|
| 2016 |
Dajon M, Iribarren K, Cremer I. Abstract A124: Protumoral effects of TLR7 in lung tumors Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A124 |
0.65 |
|
| 2015 |
Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673 |
0.496 |
|
| 2015 |
Michels J, Adam J, Goubar A, Obrist F, Damotte D, Robin A, Alifano M, Vitale I, Olaussen KA, Girard P, Cremer I, Castedo M, Soria JC, Kroemer G. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 26: 2470-7. PMID 26387143 DOI: 10.1093/Annonc/Mdv393 |
0.461 |
|
| 2015 |
Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/Fimmu.2015.00402 |
0.455 |
|
| 2015 |
Messaoudene M, Périer A, Fregni G, Neves E, Zitvogel L, Cremer I, Chanal J, Sastre-Garau X, Deschamps L, Marinho E, Larousserie F, Maubec E, Avril MF, Caignard A. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients. Plos One. 10: e0133363. PMID 26218530 DOI: 10.1371/Journal.Pone.0133363 |
0.47 |
|
| 2015 |
Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531 |
0.354 |
|
| 2015 |
Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866 |
0.374 |
|
| 2015 |
Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814 |
0.382 |
|
| 2015 |
Dajon M, Iribarren K, Cremer I. Dual roles of TLR7 in the lung cancer microenvironment. Oncoimmunology. 4: e991615. PMID 25949912 DOI: 10.4161/2162402X.2014.991615 |
0.619 |
|
| 2015 |
Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940 |
0.504 |
|
| 2015 |
Metidji A, Rieder SA, Glass DD, Cremer I, Punkosdy GA, Shevach EM. IFN-α/β receptor signaling promotes regulatory T cell development and function under stress conditions. Journal of Immunology (Baltimore, Md. : 1950). 194: 4265-76. PMID 25795758 DOI: 10.4049/Jimmunol.1500036 |
0.763 |
|
| 2015 |
Devêvre EF, Renovato-Martins M, Clément K, Sautès-Fridman C, Cremer I, Poitou C. Profiling of the three circulating monocyte subpopulations in human obesity. Journal of Immunology (Baltimore, Md. : 1950). 194: 3917-23. PMID 25786686 DOI: 10.4049/Jimmunol.1402655 |
0.314 |
|
| 2014 |
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, ... ... Cremer I, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 3: e955691. PMID 25941621 DOI: 10.4161/21624011.2014.955691 |
0.448 |
|
| 2014 |
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424 |
0.389 |
|
| 2014 |
Alifano M, Mansuet-Lupo A, Lococo F, Roche N, Bobbio A, Canny E, Schussler O, Dermine H, Régnard JF, Burroni B, Goc J, Biton J, Ouakrim H, Cremer I, Dieu-Nosjean MC, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. Plos One. 9: e106914. PMID 25238252 DOI: 10.1371/Journal.Pone.0106914 |
0.568 |
|
| 2014 |
Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/Onci.28694 |
0.302 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/Onci.29179 |
0.458 |
|
| 2014 |
Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/Onci.29030 |
0.46 |
|
| 2014 |
Chatterjee S, Crozet L, Damotte D, Iribarren K, Schramm C, Alifano M, Lupo A, Cherfils-Vicini J, Goc J, Katsahian S, Younes M, Dieu-Nosjean MC, Fridman WH, Sautès-Fridman C, Cremer I. TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer. Cancer Research. 74: 5008-18. PMID 25074614 DOI: 10.1158/0008-5472.Can-13-2698 |
0.765 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344 |
0.326 |
|
| 2014 |
Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 3: e27878. PMID 24800173 DOI: 10.4161/Onci.27878 |
0.458 |
|
| 2014 |
Mansuet-Lupo A, Bobbio A, Blons H, Becht E, Ouakrim H, Didelot A, Charpentier MC, Bain S, Marmey B, Bonjour P, Biton J, Cremer I, Dieu-Nosjean MC, Sautès-Fridman C, Régnard JF, et al. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: The experience of a French cohort Chest. 146: 633-643. PMID 24676429 DOI: 10.1378/Chest.13-2499 |
0.412 |
|
| 2014 |
Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, Validire P, Damotte D, Alifano M, Magdeleinat P, Cremer I, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. American Journal of Respiratory and Critical Care Medicine. 189: 832-44. PMID 24484236 DOI: 10.1164/Rccm.201309-1611Oc |
0.538 |
|
| 2014 |
Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L, Ouakrim H, Becht E, Alifano M, Validire P, Remark R, Hammond SA, Cremer I, Damotte D, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Research. 74: 705-15. PMID 24366885 DOI: 10.1158/0008-5472.Can-13-1342 |
0.586 |
|
| 2014 |
Messaoudene M, Fregni G, Fourmentraux-Neves E, Chanal J, Maubec E, Mazouz-Dorval S, Couturaud B, Girod A, Sastre-Garau X, Albert S, Guédon C, Deschamps L, Mitilian D, Cremer I, Jacquelot N, et al. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma. Cancer Research. 74: 81-92. PMID 24225017 DOI: 10.1158/0008-5472.Can-13-1303 |
0.433 |
|
| 2013 |
Fregni G, Messaoudene M, Fourmentraux-Neves E, Mazouz-Dorval S, Chanal J, Maubec E, Marinho E, Scheer-Senyarich I, Cremer I, Avril MF, Caignard A. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages. Plos One. 8: e76928. PMID 24204708 DOI: 10.1371/Journal.Pone.0076928 |
0.48 |
|
| 2013 |
Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M, Crozet L, Ouakrim H, Goc J, Cazes A, Fléjou JF, Gibault L, Verkarre V, Régnard JF, Pagès ON, et al. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4079-91. PMID 23785047 DOI: 10.1158/1078-0432.Ccr-12-3847 |
0.567 |
|
| 2013 |
Rusakiewicz S, Semeraro M, Sarabi M, Desbois M, Locher C, Mendez R, Vimond N, Concha A, Garrido F, Isambert N, Chaigneau L, Le Brun-Ly V, Dubreuil P, Cremer I, Caignard A, et al. Immune in filtrates are prognostic factors in localized gastrointestinal stromal tumors Cancer Research. 73: 3499-3510. PMID 23592754 DOI: 10.1158/0008-5472.Can-13-0371 |
0.546 |
|
| 2013 |
Gillard-Bocquet M, Caer C, Cagnard N, Crozet L, Perez M, Fridman WH, Sautès-Fridman C, Cremer I. Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells. Frontiers in Immunology. 4: 19. PMID 23382731 DOI: 10.3389/Fimmu.2013.00019 |
0.612 |
|
| 2013 |
Fridman WH, Dieu-Nosjean MC, Pagès F, Cremer I, Damotte D, Sautès-Fridman C, Galon J. The immune microenvironment of human tumors: general significance and clinical impact. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 117-22. PMID 23108700 DOI: 10.1007/S12307-012-0124-9 |
0.572 |
|
| 2012 |
Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, ... ... Cremer I, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Reports. 2: 257-69. PMID 22854025 DOI: 10.1016/J.Celrep.2012.06.017 |
0.4 |
|
| 2012 |
Cremer I, Fridman WH, Sautès-Fridman C. Tumor microenvironment in NSCLC suppresses NK cells function. Oncoimmunology. 1: 244-246. PMID 22720258 DOI: 10.4161/Onci.1.2.18309 |
0.597 |
|
| 2012 |
Goc J, Chaisemartin Ld, Damotte D, Validire P, Lupo A, Devevre E, Remark R, Magdeleinat P, Alifano M, Cremer I, Fridman W, Sautès-Fridman C, Dieu-Nosjean M. Abstract LB-498: Density of tertiary lymphoid structures is associated with activated and effector-memory T lymphocyte infiltration in human lung tumor Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-498 |
0.582 |
|
| 2012 |
Remark R, Crozet L, Lupo A, Alifano M, Riquet M, Cremer I, Dieu-Nosjean M, Goc J, Mlecnik B, Cazes A, Fléjou J, Gibault L, Verkarre V, Oudard S, Pagès O, et al. Abstract LB-497: Primary tumor localization determines the metastatic immune profile Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-497 |
0.61 |
|
| 2011 |
de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, Cremer I, Fridman WH, Sautès-Fridman C, Dieu-Nosjean MC. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Research. 71: 6391-9. PMID 21900403 DOI: 10.1158/0008-5472.Can-11-0952 |
0.522 |
|
| 2011 |
Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P, André P, Dieu-Nosjean MC, Alifano M, Régnard JF, Fridman WH, Sautès-Fridman C, Cremer I. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Research. 71: 5412-22. PMID 21708957 DOI: 10.1158/0008-5472.Can-10-4179 |
0.715 |
|
| 2011 |
Delahaye NF, Rusakiewicz S, Martins I, Ménard C, Roux S, Lyonnet L, Paul P, Sarabi M, Chaput N, Semeraro M, Minard-Colin V, Poirier-Colame V, Chaba K, Flament C, Baud V, ... ... Cremer I, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nature Medicine. 17: 700-7. PMID 21552268 DOI: 10.1038/Nm.2366 |
0.478 |
|
| 2011 |
Sautès-Fridman C, Cherfils-Vicini J, Damotte D, Fisson S, Fridman WH, Cremer I, Dieu-Nosjean MC. Tumor microenvironment is multifaceted. Cancer Metastasis Reviews. 30: 13-25. PMID 21271351 DOI: 10.1007/S10555-011-9279-Y |
0.827 |
|
| 2011 |
Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D, Pagès F, Tartour E, Sautès-Fridman C. Immune infiltration in human cancer: prognostic significance and disease control. Current Topics in Microbiology and Immunology. 344: 1-24. PMID 20512556 DOI: 10.1007/82_2010_46 |
0.603 |
|
| 2010 |
Cherfils-Vicini J, Damotte D, Fridman WH, Sautès-Fridman C, Cremer I. [Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance]. Medecine Sciences : M/S. 26: 435-7. PMID 20412752 DOI: 10.1051/Medsci/2010264435 |
0.789 |
|
| 2010 |
Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH, Damotte D, Sautès-Fridman C, Cremer I. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. The Journal of Clinical Investigation. 120: 1285-97. PMID 20237413 DOI: 10.1172/Jci36551 |
0.723 |
|
| 2008 |
Cherfils-Vicini J, Vingert B, Varin A, Tartour E, Fridman WH, Sautès-Fridman C, Régnier CH, Cremer I. Characterization of immune functions in TRAF4-deficient mice. Immunology. 124: 562-74. PMID 18284467 DOI: 10.1111/J.1365-2567.2008.02810.X |
0.762 |
|
| 2008 |
Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells. Aids (London, England). 22: 217-26. PMID 18097224 DOI: 10.1097/Qad.0B013E3282F46E7C |
0.746 |
|
| 2006 |
Camilleri-Broët S, Cremer I, Marmey B, Comperat E, Viguié F, Audouin J, Rio MC, Fridman WH, Sautès-Fridman C, Régnier CH. TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene. 26: 142-7. PMID 16799635 DOI: 10.1038/sj.onc.1209762 |
0.388 |
|
| 2002 |
Cremer I, Dieu-Nosjean MC, Maréchal S, Dezutter-Dambuyant C, Goddard S, Adams D, Winter N, Menetrier-Caux C, Sautès-Fridman C, Fridman WH, Mueller CG. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood. 100: 3646-55. PMID 12393586 DOI: 10.1182/Blood-2002-01-0312 |
0.427 |
|
| 2001 |
Mueller CG, Cremer I, Paulet PE, Niida S, Maeda N, Lebeque S, Fridman WH, Sautès-Fridman C. Mannose receptor ligand-positive cells express the metalloprotease decysin in the B cell follicle. Journal of Immunology (Baltimore, Md. : 1950). 167: 5052-60. PMID 11673514 DOI: 10.4049/Jimmunol.167.9.5052 |
0.497 |
|
| 1997 |
Vieillard V, Cremer I, Lauret E, Rozenbaum W, Debré P, Autran B, De Maeyer E. Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proceedings of the National Academy of Sciences of the United States of America. 94: 11595-600. PMID 9326655 DOI: 10.1073/Pnas.94.21.11595 |
0.3 |
|
| Show low-probability matches. |